Our Science
To comprehensively elucidate plant and fungal metabolomes for clinical use and semi-synthetic scaffold inspiration.
Our Process
We bring science and innovation together
Research into the molecular composition and characterization of a range of natural plant, fungal and microbiological psychedelic extracts and associated non-psychedelic compounds for treatment of TACs (including cluster headaches) and Migraine is underway.
The functional characterization of small signaling molecules that potentiate neural, endocrine, immune and metabolic function will be investigated with collaborating institutions and experts to identify target mechanisms.
It is our intention to provision clinical trials and compounding Pharmaceutical companies with tryptamines derived from extracts as a scalable solution to ramping up the availability and access to quality controlled APIs.
